Article
"Let us not take ourselves too seriously. None of us has a monopoly on wisdom."
New research links retinal imaging and deep learning to improved schizophrenia detection
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
FDA accepts revised supplemental New Drug Application for IZERVAY
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Heidelberg Engineering announces FDA clearance for ANTERION Epithelial Thickness Module, Ectasia View
FDA grants rare pediatric disease designation for retinitis pigmentosa gene therapy candidate VG901 from ViGeneron